{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:02:55Z","timestamp":1789380175685,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"DOI":"10.1007\/s40801-026-00581-7","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:09:07Z","timestamp":1789376947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in the Use and Costs of Medications for Respiratory Management Included in the 2022 Benefit Plan of the Colombia Health System"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8458-0986","authenticated-orcid":false,"given":"Manuel Enrique","family":"Machado-Duque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4245-0101","authenticated-orcid":false,"given":"Luis Fernando","family":"Valladales-Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2500-7658","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Gaviria-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Albanes-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanny","family":"Mesa-Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Camila","family":"Delgado-Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Camila","family":"Oyuela-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Rubio-Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-0936","authenticated-orcid":false,"given":"Jorge Enrique","family":"Machado-Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"581_CR1","unstructured":"Ley 100 de 1993 por la cual se crea el sistema de seguridad social integral y se dictan otras disposiciones, (23 de diciembre de 1993)."},{"issue":"6","key":"581_CR2","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1590\/S1413-81232011000600020","volume":"16","author":"CAA Calder\u00f3n","year":"2011","unstructured":"Calder\u00f3n CAA, Botero JC, Bola\u00f1os JO, Mart\u00ednez RR. Sistema de salud en Colombia: 20 a\u00f1os de logros y problemas. Ci\u00eancia and; Sa\u00fade Coletiva. 2011;16(6):2817\u201328.","journal-title":"Ci\u00eancia & Sa\u00fade Coletiva"},{"issue":"9370","key":"581_CR3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(03)13375-2","volume":"361","author":"R Laing","year":"2003","unstructured":"Laing R, Waning B, Gray A, Ford N, t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361(9370):1723\u20139.","journal-title":"Lancet"},{"key":"581_CR4","unstructured":"Ley 1438 de 2011 por medio de la cual se reforma el Sistema General de Seguridad Social en Salud y se dictan otras disposiciones, (19 de enero de 2011)."},{"key":"581_CR5","unstructured":"Social MdSyP. Resoluci\u00f3n 2292 de 2021 por la cual se actualizan y establecen los servicios y tecnolog\u00edas de salud financiados con recursos de la Unidad de Pago por Capitaci\u00f3n (UPC). 23 de diciembre de 2021."},{"key":"581_CR6","unstructured":"Global initiative for chronic obstructive lung disease. global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2024. Updated 2024. Available from: https:\/\/goldcopd.org\/2024-gold-report\/."},{"key":"581_CR7","unstructured":"Global initiative for asthma. global strategy for asthma management and prevention, 2023. Updated July 2023. Available from: www.ginasthma.org."},{"issue":"5","key":"581_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.661","volume":"8","author":"JS Franco","year":"2020","unstructured":"Franco JS, Vizcaya D. Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: a systematic review. Pharmacol Res Perspect. 2020;8(5):e00661.","journal-title":"Pharmacol Res Perspect"},{"key":"581_CR9","volume-title":"Manual para la elaboraci\u00f3n de evaluaciones econ\u00f3micas en salud","author":"Instituto de Evaluaci\u00f3n Tecnol\u00f3gica en Salud","year":"2014","unstructured":"Instituto de Evaluaci\u00f3n Tecnol\u00f3gica en Salud. Manual para la elaboraci\u00f3n de evaluaciones econ\u00f3micas en salud. Bogot\u00e1: IETS; 2014."},{"key":"581_CR10","volume-title":"Python 3 reference manual","author":"G Van Rossum","year":"2009","unstructured":"Van Rossum G, Drake FL. Python 3 reference manual. Scotts Valley: CreateSpace; 2009."},{"key":"581_CR11","unstructured":"The pandas development team. pandas-dev\/pandas: Pandas 1.5.2. 2022."},{"issue":"7825","key":"581_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris CR, Millman KJ, van der Walt SJ, Gommers R, Virtanen P, Cournapeau D, et al. Array programming with NumPy. Nature. 2020;585(7825):357\u201362.","journal-title":"Nature"},{"issue":"1","key":"581_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S2213-2600(22)00494-5","volume":"11","author":"P Venkatesan","year":"2023","unstructured":"Venkatesan P. GOLD COPD report: 2023 update. Lancet Respir Med. 2023;11(1):18.","journal-title":"Lancet Respir Med"},{"key":"581_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/1753466620926802","volume":"14","author":"K Souliotis","year":"2020","unstructured":"Souliotis K, Silva Miguel L, Hillas G, Borges M, Papageorgiou G, Viana D, et al. The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2020;14:1753466620926802.","journal-title":"Ther Adv Respir Dis"},{"issue":"7","key":"581_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S2213-2600(23)00230-8","volume":"11","author":"P Venkatesan","year":"2023","unstructured":"Venkatesan P. 2023 GINA report for asthma. Lancet Respir Med. 2023;11(7):589.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"581_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJMcp2304871","volume":"389","author":"G Mosnaim","year":"2023","unstructured":"Mosnaim G. Asthma in adults. N Engl J Med. 2023;389(11):1023\u201331.","journal-title":"N Engl J Med"},{"key":"581_CR17","unstructured":"Ministerio de Salud y Protecci\u00f3n Social. Rep\u00fablica de Colombia. Valor de la Unidad de Pago por Capitaci\u00f3n (UPC) 2024 \u2013 Resoluci\u00f3n 2364 de 2023, (2023)."},{"key":"581_CR18","unstructured":"Corte Constitucional cita a EPS y a Minsalud para hablar de la UPC en la salud. El Espectador. 2024 04 de abril de 2024."},{"key":"581_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.vhri.2015.02.002","volume":"8","author":"JE Machado-Alba","year":"2015","unstructured":"Machado-Alba JE, Torres D, Portilla A, Felipe RA. The results of the inclusion of new medications in the obligatory health system plan in Colombia, 2012\u20132013. Value Health Reg Issues. 2015;8:28\u201335.","journal-title":"Value Health Reg Issues"},{"key":"581_CR20","doi-asserted-by":"crossref","unstructured":"Espinosa O, Bejarano V, Ramos J. Predictability and financial sufficiency of health insurance in Colombia: an actuarial analysis with a bayesian approach. N Am Actuarial J. 2024; 28(2):320\u201336","DOI":"10.1080\/10920277.2023.2197475"},{"issue":"1","key":"581_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13561-022-00416-5","volume":"13","author":"O Espinosa","year":"2015","unstructured":"Espinosa O, Bejarano V, Ramos J, Mart\u00ednez B. Statistical actuarial estimation of the capitation payment unit from copula functions and deep learning: historical comparability analysis for the Colombian health system, 2015\u20132021. Health Econ Rev. 2015;13(1):15.","journal-title":"Health Econ Rev"},{"key":"581_CR22","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.2147\/COPD.S79635","volume":"10","author":"F Braido","year":"2015","unstructured":"Braido F, Lavorini F, Blasi F, Baiardini I, Canonica GW. Switching treatments in COPD: implications for costs and treatment adherence. Int J Chron Obstruct Pulmon Dis. 2015;10:2601\u20138.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"581_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2147\/COPD.S25805","volume":"7","author":"CV Asche","year":"2012","unstructured":"Asche CV, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, et al. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis. 2012;7:201\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"581_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/pop.2020.0013","volume":"24","author":"Q Xu","year":"2021","unstructured":"Xu Q, Laxa SS, Serna O, Sansgiry SS. Factors associated with entering the prescription drug coverage gap among medicare beneficiaries with chronic obstructive pulmonary disease. Popul Health Manag. 2021;24(2):241\u20138.","journal-title":"Popul Health Manag"},{"issue":"8","key":"581_CR25","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/jama.2016.11237","volume":"316","author":"AS Kesselheim","year":"2016","unstructured":"Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the united states: origins and prospects for reform. JAMA. 2016;316(8):858\u201371.","journal-title":"JAMA"},{"key":"581_CR26","unstructured":"Organizaci\u00f3n Mundial de la Salud - Organizaci\u00f3n Panamericana de la Salud. El acceso y uso racional de los medicamentos y otras tecnolog\u00edas sanitarias estrat\u00e9gicos y de alto costoEl acceso y uso racional de los medicamentos y otras tecnolog\u00edas sanitarias estrat\u00e9gicos y de alto costo Washington, D.C., EUA2016 [Available from: file:\/\/\/C:\/Users\/user\/Downloads\/pahocd5510spafinaldigital-copy.pdf."}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-026-00581-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-026-00581-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-026-00581-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:09:15Z","timestamp":1789376955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-026-00581-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":26,"alternative-id":["581"],"URL":"https:\/\/doi.org\/10.1007\/s40801-026-00581-7","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"13 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jorge Enrique Machado-Alba, MD, PhD is an Editorial Board member of Drugs\u2013Real World Outcomes but was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was endorsed by the Bioethics Committee of the Technological University of Pereira in the category of \u201crisk-free research\u201d (approval code: 03-130223) and by the ethics committee of the insurer. The principles of confidentiality of information established by the Declaration of Helsinki were respected.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for observational studies involving databases.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.E.M.D.: conceptualization, data curation, formal analysis, investigation, methodology, and writing\u2014original draft. L.F.V.R.: conceptualization, data curation, formal analysis, investigation, methodology, and writing\u2014original draft. A.G.M.: conceptualization, data curation, formal analysis, investigation, methodology, and writing\u2014original draft. J.P.A.B.: investigation, writing review, and editing. G.M.E.: investigation, writing\u2014review, and editing. A.C.D.A.: investigation, writing\u2014review, and editing M.C.O.G.: investigation, writing\u2014review, and editing. S.R.L: investigation, writing\u2014review, and editing. J.E.M.A.: conceptualization, investigation, project administration, resources, writing\u2014review, and editing. All the authors read and approved the final version.","order":5,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research received no external funding.","order":6,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":".","order":8,"name":"Ethics","label":"Data Availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}